First Implantation of a Novel Left Ventricular Assist Device: The ReliantHeart aVAD.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 28935323.
- Also identified by DOI 10.1016/j.athoracsur.2017.04.049.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
aVAD (ReliantHeart Inc, Houston, TX) is a new, compact, axial flow left ventricular assist device with novel features including real flow measurement, remote device monitoring, and a miniaturized pump housing. The aVAD received Conformité Européenne marking in August 2016. The use of this device was performed in a 61-year-old woman with severe heart failure. Following uneventful surgery, the patient recovered and was successfully discharged from the hospital.
Medical subject headings
- Equipment Design
- Heart Failure
- Heart-Assist Devices
- Patient Safety